课题基金 / 基金详情

Correlative Studies to Improve Blood and Marrow Transplantation and Leukemia Immunotherapy in Children

Correlative Studies to Improve Blood and Marrow Transplantation and Leukemia Immunotherapy in Children
改善儿童血液和骨髓移植与白血病免疫治疗的相关研究
批准号：
369398
负责人：
Schultz Kirk R
金额：
$84.32万
依托单位：
BC Children's Hospital Research Institute
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-09-01 至 2024-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=369398&lang=en
关键词：
Adolescents Children Chronic Graft-Versus-Host Disease Health Care Utilization Immune Tolerance Late Effects

项目摘要

项目成果

Schultz Kirk R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
My objective is to improve the efficacy and safety of blood and marrow transplantation (BMT), and, ultimately, to expand its clinical applications. BMT is a life-saving procedure and the only immune therapy for leukemia with established long-term curativ
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulatory Natural Killer Cell Treatment in Chronic Graft-versus-Host Disease and Solid Organ Transplantation Chronic Rejection
  • 批准号：
    441672
  • 项目类别：
    Operating Grants
  • 资助金额：
    $54.64万
  • 财政年份：
    2021
  • 负责人：
    Schultz Kirk R
  • 依托单位：
    University of British Columbia
CaPITTAL: Canadian Patient-oriented Immune Tolerance in Transplantation and Autoimmunity to improve Lives
  • 批准号：
    323878
  • 项目类别：
    Operating Grants
  • 资助金额：
    $3.64万
  • 财政年份：
    2015
  • 负责人：
    Schultz Kirk R
  • 依托单位：
    University of British Columbia
Applying Biomarkers to Long-term Effects in Child and Adolescent Cancer Treatment (ABLE Team)
Applying Biomarkers to Long-term Effects in Child and Adolescent Cancer Treatment (ABLE Team)
海外基金